Cargando…

Antibody-Dependent Cellular Cytotoxicity-Competent Antibodies against HIV-1-Infected Cells in Plasma from HIV-Infected Subjects

Measuring Envelope (Env)-specific antibody (Ab)-dependent cellular cytotoxicity (ADCC)-competent Abs in HIV(+) plasma is challenging because Env displays distinctive epitopes when present in a native closed trimeric conformation on infected cells or in a CD4-bound conformation on uninfected bystande...

Descripción completa

Detalles Bibliográficos
Autores principales: Dupuy, Franck P., Kant, Sanket, Barbé, Alexandre, Routy, Jean-Pierre, Bruneau, Julie, Lebouché, Bertrand, Tremblay, Cécile, Pazgier, Marzena, Finzi, Andrés, Bernard, Nicole F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918083/
https://www.ncbi.nlm.nih.gov/pubmed/31848282
http://dx.doi.org/10.1128/mBio.02690-19
_version_ 1783480508266577920
author Dupuy, Franck P.
Kant, Sanket
Barbé, Alexandre
Routy, Jean-Pierre
Bruneau, Julie
Lebouché, Bertrand
Tremblay, Cécile
Pazgier, Marzena
Finzi, Andrés
Bernard, Nicole F.
author_facet Dupuy, Franck P.
Kant, Sanket
Barbé, Alexandre
Routy, Jean-Pierre
Bruneau, Julie
Lebouché, Bertrand
Tremblay, Cécile
Pazgier, Marzena
Finzi, Andrés
Bernard, Nicole F.
author_sort Dupuy, Franck P.
collection PubMed
description Measuring Envelope (Env)-specific antibody (Ab)-dependent cellular cytotoxicity (ADCC)-competent Abs in HIV(+) plasma is challenging because Env displays distinctive epitopes when present in a native closed trimeric conformation on infected cells or in a CD4-bound conformation on uninfected bystander cells. We developed an ADCC model which distinguishes Env-specific ADCC-competent Abs based on their capacity to eliminate infected, bystander, or Env rgp120-coated cells as a surrogate for shed gp120 on bystander cells. A panel of monoclonal Abs (MAbs), used to opsonize these target cells, showed that infected cells were preferentially recognized/eliminated by MAbs to CD4 binding site, V3 loop, and viral spike epitopes whereas bystander/coated cells were preferentially recognized/eliminated by Abs to CD4-induced (CD4i) epitopes. In HIV-positive (HIV(+)) plasma, Env-specific Abs recognized and supported ADCC of infected cells, though a majority were directed toward CD4i epitopes on bystander cells. For ADCC activity to be effective in HIV control, ADCC-competent Abs need to target genuinely infected cells.
format Online
Article
Text
id pubmed-6918083
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-69180832019-12-23 Antibody-Dependent Cellular Cytotoxicity-Competent Antibodies against HIV-1-Infected Cells in Plasma from HIV-Infected Subjects Dupuy, Franck P. Kant, Sanket Barbé, Alexandre Routy, Jean-Pierre Bruneau, Julie Lebouché, Bertrand Tremblay, Cécile Pazgier, Marzena Finzi, Andrés Bernard, Nicole F. mBio Research Article Measuring Envelope (Env)-specific antibody (Ab)-dependent cellular cytotoxicity (ADCC)-competent Abs in HIV(+) plasma is challenging because Env displays distinctive epitopes when present in a native closed trimeric conformation on infected cells or in a CD4-bound conformation on uninfected bystander cells. We developed an ADCC model which distinguishes Env-specific ADCC-competent Abs based on their capacity to eliminate infected, bystander, or Env rgp120-coated cells as a surrogate for shed gp120 on bystander cells. A panel of monoclonal Abs (MAbs), used to opsonize these target cells, showed that infected cells were preferentially recognized/eliminated by MAbs to CD4 binding site, V3 loop, and viral spike epitopes whereas bystander/coated cells were preferentially recognized/eliminated by Abs to CD4-induced (CD4i) epitopes. In HIV-positive (HIV(+)) plasma, Env-specific Abs recognized and supported ADCC of infected cells, though a majority were directed toward CD4i epitopes on bystander cells. For ADCC activity to be effective in HIV control, ADCC-competent Abs need to target genuinely infected cells. American Society for Microbiology 2019-12-17 /pmc/articles/PMC6918083/ /pubmed/31848282 http://dx.doi.org/10.1128/mBio.02690-19 Text en Copyright © 2019 Dupuy et al. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Dupuy, Franck P.
Kant, Sanket
Barbé, Alexandre
Routy, Jean-Pierre
Bruneau, Julie
Lebouché, Bertrand
Tremblay, Cécile
Pazgier, Marzena
Finzi, Andrés
Bernard, Nicole F.
Antibody-Dependent Cellular Cytotoxicity-Competent Antibodies against HIV-1-Infected Cells in Plasma from HIV-Infected Subjects
title Antibody-Dependent Cellular Cytotoxicity-Competent Antibodies against HIV-1-Infected Cells in Plasma from HIV-Infected Subjects
title_full Antibody-Dependent Cellular Cytotoxicity-Competent Antibodies against HIV-1-Infected Cells in Plasma from HIV-Infected Subjects
title_fullStr Antibody-Dependent Cellular Cytotoxicity-Competent Antibodies against HIV-1-Infected Cells in Plasma from HIV-Infected Subjects
title_full_unstemmed Antibody-Dependent Cellular Cytotoxicity-Competent Antibodies against HIV-1-Infected Cells in Plasma from HIV-Infected Subjects
title_short Antibody-Dependent Cellular Cytotoxicity-Competent Antibodies against HIV-1-Infected Cells in Plasma from HIV-Infected Subjects
title_sort antibody-dependent cellular cytotoxicity-competent antibodies against hiv-1-infected cells in plasma from hiv-infected subjects
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918083/
https://www.ncbi.nlm.nih.gov/pubmed/31848282
http://dx.doi.org/10.1128/mBio.02690-19
work_keys_str_mv AT dupuyfranckp antibodydependentcellularcytotoxicitycompetentantibodiesagainsthiv1infectedcellsinplasmafromhivinfectedsubjects
AT kantsanket antibodydependentcellularcytotoxicitycompetentantibodiesagainsthiv1infectedcellsinplasmafromhivinfectedsubjects
AT barbealexandre antibodydependentcellularcytotoxicitycompetentantibodiesagainsthiv1infectedcellsinplasmafromhivinfectedsubjects
AT routyjeanpierre antibodydependentcellularcytotoxicitycompetentantibodiesagainsthiv1infectedcellsinplasmafromhivinfectedsubjects
AT bruneaujulie antibodydependentcellularcytotoxicitycompetentantibodiesagainsthiv1infectedcellsinplasmafromhivinfectedsubjects
AT lebouchebertrand antibodydependentcellularcytotoxicitycompetentantibodiesagainsthiv1infectedcellsinplasmafromhivinfectedsubjects
AT tremblaycecile antibodydependentcellularcytotoxicitycompetentantibodiesagainsthiv1infectedcellsinplasmafromhivinfectedsubjects
AT pazgiermarzena antibodydependentcellularcytotoxicitycompetentantibodiesagainsthiv1infectedcellsinplasmafromhivinfectedsubjects
AT finziandres antibodydependentcellularcytotoxicitycompetentantibodiesagainsthiv1infectedcellsinplasmafromhivinfectedsubjects
AT bernardnicolef antibodydependentcellularcytotoxicitycompetentantibodiesagainsthiv1infectedcellsinplasmafromhivinfectedsubjects